Press ReleasesIndustrialsAktietilbagekøb 23-27 juni 2025

June 30, 2025

Aktietilbagekøb 23-27 juni 2025

Herlev 30 juni 2025
Selskabsmeddelelse 29/2025

RESULTAT AF AKTIETILBAGEKØB:
Selskabet meddelte i selskabsmeddelelse 21/2025, at man havde besluttet at iværksætte et aktietilbagekøb på køb af maksimalt DKK 5.000.000 i perioden 14 maj – 18 juli 2025, begge dage inklusive.

Source: https://www.globenewswire.com/news-release/2025/06/30/3107167/0/da/Aktietilbagek%C3%B8b-23-27-juni-2025.html

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares

globenewswire

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

Commodities & Resources PTE Ltd. Announces Acquisition of Shares of Belmont Resources Inc. Pursuant to Private Placement

APPLOVIN ALERT: Bragar Eagel & Squire, P.C. is Investigating AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Gwo Xi Stem Cell Company Powers Local Regenerative Medicine, Partners with Japan to Open a New Era

Aktietilbagekøb 23-27 juni 2025

Commodities & Resources PTE Ltd. Announces Acquisition of Shares of Belmont Resources Inc. Pursuant to Private Placement

APPLOVIN ALERT: Bragar Eagel & Squire, P.C. is Investigating AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Gwo Xi Stem Cell Company Powers Local Regenerative Medicine, Partners with Japan to Open a New Era

World’s Best Glacier Photos Launch in Global “Walk of Water” Exhibition

Eye Level Malaysia Ignites Learning Joy with Mid-Year Promo & Exclusive Block Sets!

Minsud Announces Closing of Over-Subscribed Private Placement

Recent News

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Jacobio’s IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted

Explore

Press Releases

News & Opinion

Living

Others

Follow us

MODE Global Technology Suite Gains Momentum

Navigator Gas Announces Results of 2025 Annual General Meeting of Shareholders

DHL Express Canada callously threatens to lock out Unifor members